No Data
No Data
Express News | Allovir Inc - on June 5 Entered Into a Termination of Sublease Agreement With Amag Pharmaceuticals, Inc
Analysts Have Conflicting Sentiments on These Healthcare Companies: AlloVir (ALVR), Guardant Health (GH) and Centessa Pharmaceuticals (CNTA)
AlloVir | 10-Q: Quarterly report
Maintaining a Hold: AlloVir's Strategic Uncertainty and Financial Outlook
ALLOVIR SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In AlloVir To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $25,000 investing in AlloVir stock or options between March 22, 2022 and December 21, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson
AlloVir Faces Delisting Risk, Considers Reverse Split to Comply
No Data